[EN] NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS<br/>[FR] NOUVEAUX AGONISTES DE RÉCEPTEURS ADRÉNERGIQUES BÊTA 3 DÉRIVÉS DE PYRROLIDINE
申请人:MERCK SHARP & DOHME
公开号:WO2011025690A1
公开(公告)日:2011-03-03
The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.
,4'-piperidines] were prepared and examined for their biological activity. Several of the compounds inhibited the compound 48/80 induced histamine release from isolated rat peritoneal mast cells. The structural requirements for this activity in the present series are discussed.
One-Pot Synthesis of Spiro Isochromane-3,3′-piperidines, -3,4′-piperidines and -3,3′-pyrrolidines
作者:J. W. Butcher、D. A. Claremon
DOI:10.1055/s-1993-25832
日期:——
Spiro isochromane-1-ones 1 were treated with lithium aluminum hydride or Grignard reagents to afford diol intermediates 2, which cyclize in 85 % phosphoric acid at 100°C to spiro isochromanes 3 in 72-94 % isolated yields.